Clinical Trials Directory

Trials / Completed

CompletedNCT00362011

Effect of Chia Seeds (Salvia Hispanica L.) on Glucose Control in Patients With Type 2 Diabetes

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
Sponsor
Unity Health Toronto · Academic / Other
Sex
All
Age
35 Years – 75 Years
Healthy volunteers

Summary

The purpose of this study is to determine whether the addition of Salvia hispanica L. Alba (Salba) to the conventional treatment for diabetes is associated with improvement in major and emerging cardiovascular risk factors in people with type 2 diabetes.

Detailed description

Cohort studies have linked consumption of whole grain with a reduction in the risk of developing diabetes and heart disease. Grain of the plant Salvia hispanica alba (Salba) contain a high concentration of ω-3 fatty acids in addition to being a rich source of vegetable protein, fiber, calcium and antioxidants which have cardiovascular protective effect. To address the paucity of randomized, well-controlled clinical studies supporting the long-term cardioprotective benefits of whole grain we investigated the effects of a novel grain Salba in type 2 diabetes. Comparison(s): Participants on a conventional diabetes diet (50% carbohydrate, 20% protein, 30% fat) receive either addition of Salba or matched control supplement for 12 weeks separated by a 4-week washout period.

Conditions

Interventions

TypeNameDescription
BEHAVIORALSalba diet

Timeline

Start date
2001-03-01
First posted
2006-08-09
Last updated
2006-08-09

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT00362011. Inclusion in this directory is not an endorsement.